MiMedx Group Inc
MDXG7.255USD
+0.095+1.33%
Horário de mercado （ET）Cotações atrasadas em 15 min
1.07BValor de mercado
26.71P/L TTM
Mais detalhes de MiMedx Group Inc Empresa
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
Informações da empresa
Código da empresaMDXG
Nome da EmpresaMiMedx Group Inc
Data de listagemAug 20, 2007
CEOMr. Joseph H. (Joe) Capper
Número de funcionários837
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 20
Endereço1775 W Oak Commons Court, Ne
CidadeMARIETTA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal30062
Telefone17706519100
Sitehttps://mimedx.com/
Código da empresaMDXG
Data de listagemAug 20, 2007
CEOMr. Joseph H. (Joe) Capper
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
89.04K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Independent Director
Independent Director
--
--
Mr. Douglas C. Rice
Mr. Douglas C. Rice
Chief Financial Officer
Chief Financial Officer
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
529.53K
+60.69%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
212.77K
+15.53%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
190.25K
-57.15%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
+18.66%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
89.04K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
57.60K
+98.69%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por EmpresaUSD
Nome
Receita
Proporção
Advanced Wound Care
56.07M
63.57%
Surgical
32.13M
36.43%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Advanced Wound Care
56.07M
63.57%
Surgical
32.13M
36.43%
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
EW Healthcare Partners
19.06%
BlackRock Institutional Trust Company, N.A.
5.80%
Trigran Investments, Inc.
5.14%
The Vanguard Group, Inc.
4.52%
Paradigm Capital Management, Inc.
3.17%
Other
62.33%
Investidores
Investidores
Proporção
EW Healthcare Partners
19.06%
BlackRock Institutional Trust Company, N.A.
5.80%
Trigran Investments, Inc.
5.14%
The Vanguard Group, Inc.
4.52%
Paradigm Capital Management, Inc.
3.17%
Other
62.33%
Tipos de investidores
Investidores
Proporção
Venture Capital
19.09%
Investment Advisor/Hedge Fund
18.48%
Investment Advisor
18.17%
Hedge Fund
11.43%
Research Firm
2.06%
Individual Investor
1.84%
Pension Fund
0.46%
Bank and Trust
0.39%
Sovereign Wealth Fund
0.28%
Other
27.81%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
450
106.68M
72.20%
-3.42M
2025Q1
460
106.92M
72.40%
-5.30M
2024Q4
455
107.57M
73.21%
-3.01M
2024Q3
429
103.18M
70.48%
-6.90M
2024Q2
424
100.59M
68.44%
-3.52M
2024Q1
405
106.53M
74.65%
+1.42M
2023Q4
391
100.91M
86.85%
+27.80M
2023Q3
385
72.00M
62.20%
-22.83M
2023Q2
375
65.55M
56.85%
-21.21M
2023Q1
361
82.89M
72.72%
-885.21K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
EW Healthcare Partners
28.20M
19.09%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
8.58M
5.81%
+179.59K
+2.14%
Mar 31, 2025
Trigran Investments, Inc.
7.60M
5.15%
-21.96K
-0.29%
Mar 31, 2025
The Vanguard Group, Inc.
6.69M
4.53%
+5.46K
+0.08%
Mar 31, 2025
Paradigm Capital Management, Inc.
4.68M
3.17%
-2.73K
-0.06%
Mar 31, 2025
State Street Global Advisors (US)
3.46M
2.34%
+189.21K
+5.79%
Mar 31, 2025
First Light Asset Management, LLC
3.45M
2.34%
+109.21K
+3.27%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.91M
1.97%
+133.11K
+4.79%
Mar 31, 2025
Cannell Capital, LLC
2.13M
1.44%
-1.51M
-41.39%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.01M
1.36%
+206.79K
+11.47%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Invesco NASDAQ Future Gen 200 ETF
0.43%
First Trust Small Cap Growth AlphaDEX Fund
0.26%
ALPS Barron's 400 ETF
0.18%
iShares Micro-Cap ETF
0.16%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.14%
WisdomTree US SmallCap Quality Growth Fund
0.13%
Franklin US Small Cap Multifactor Index ETF
0.12%
VictoryShares Small Cap Free Cash Flow ETF
0.1%
SPDR S&P Biotech ETF
0.1%
First Trust Small Cap Core Alphadex Fund
0.1%
Ver Mais
Invesco NASDAQ Future Gen 200 ETF
Proporção0.43%
First Trust Small Cap Growth AlphaDEX Fund
Proporção0.26%
ALPS Barron's 400 ETF
Proporção0.18%
iShares Micro-Cap ETF
Proporção0.16%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.14%
WisdomTree US SmallCap Quality Growth Fund
Proporção0.13%
Franklin US Small Cap Multifactor Index ETF
Proporção0.12%
VictoryShares Small Cap Free Cash Flow ETF
Proporção0.1%
SPDR S&P Biotech ETF
Proporção0.1%
First Trust Small Cap Core Alphadex Fund
Proporção0.1%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
